High risk, low evidence: Need for more research on lipid-lowering therapies for people with type 1 diabetes. Lan NSR, Fegan PG, Jenkins AJ. J Diabetes Complications 2026;40:109268.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lan NSR, Fegan PG, Jenkins AJ. High risk, low evidence: Need for more research on lipid-lowering therapies for people with type 1 diabetes. J Diabetes Complications 2026;40:109268.
PMID: 41581317